The Board of Directors of Genovis AB (publ) has decided to schedule the January – September 2013 interim report earlier. The report was to have been published on November 28 and the new publication date is November 18, 2013. CEO Sarah Fredriksson will comment on the interim report at Financial Meetings Øresund’s morning meeting on November 18. Redeye analyst Klas Palin will ask questions immediately after the report is presented. The presentation will take place from 8 a.m. to 10 a.m. at Årstiderna By The Sea, Dockgatan 1, Malmö. Breakfast is served from 7:30. The morning meeting is free, but participants must register by November 13: rapport@financialmeetings.se The presentation will be direct broadcast on the following technical platforms: www.genovis.com/investors-swedish www.financialmeetings.se www.redeye.se ABOUT FINANCIAL MEETINGS ØRESUND Financial Meetings Øresund was founded in 2013 and is a brand new financial meeting place, an arena, with interesting financial arrangements for and with Öresund companies, market analysts, investors and media. For more information, please contact: Sarah Fredriksson, CEO, Genovis AB Tel: 46 (0)46 -101235 sarah.fredriksson@genovis.com ABOUT GENOVIS Genovis’ business concept is to develop, produce and market innovative technologies that facilitate and enable development of new treatment methods and diagnostics for customers in the medical device and pharmaceutical industries. The Group consists of Genovis AB and the subsidiary GeccoDots AB. Genovis develops and sells unique enzymes (protein engineering portfolio) in innovative product formats that facilitate development and quality control of and biological drugs. GeccoDots uses nanotechnology to produce a new type of contrast agent that is used in medical imaging. Genovis shares are listed on NASDAQ OMX First North, and Thenberg Fondkommission is Certified Adviser for the Company, t: 46 (0)31-745 50 00
Date change for Genovis AB January-September 2013 interim
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
NVIDIA Launches Quantum Research Center to Transform Computing
NVIDIA Establishes a Quantum Research Center for Innovation NVIDIA has taken a significant step towards the future of technology by announcing the development of a cutting-edge research center focused on quantum computing. Introducing the NVIDIA Accelerated Quantum Research Center The newly formed NVIDIA Accelerated Quantum Research Center, or NVAQC, is strategically...
Continue Reading
Discover the New GloFish® Electric Green® Angelfish Today!
Introducing the GloFish® Electric Green® Angelfish Spectrum Brands, Inc. has exciting news for aquarium enthusiasts! They have unveiled the latest addition to their vibrant family of GloFish® fluorescent fish: the GloFish® Electric Green® Angelfish. This beautiful new color adds to the popularity of the GloFish® collection, following the successful release of the...
Continue Reading
Affimed's CEO to Feature at Upcoming Healthcare Conference
Affimed CEO to Participate in Global Healthcare Conference Affimed N.V. (NASDAQ: AFMD), a clinical-stage immuno-oncology company, is excited to announce that its Chief Executive Officer, Dr. Shawn Leland, will be engaging in a fireside chat at a noteworthy healthcare conference. This event, which promises to highlight advancements in the healthcare sector, is set for a...
Continue Reading
Masimo Reveals Preliminary 2024 Financial Results and Plans
Masimo Corporation's Preliminary Financial Results for 2024 Masimo Corporation (NASDAQ: MASI) has recently unveiled its select preliminary financial results for the fourth quarter and full-year ending December 28, 2024, along with its initial guidance for the fiscal year 2025. The company’s commitment to enhancing patient outcomes and the cost of care continues to...
Continue Reading
Tile Shop Prepares for Upcoming Earnings Call in November
Tile Shop Earnings Call Scheduled for November Tile Shop Holdings, Inc. (TTSH), a leading specialty retailer in the tile industry, has announced its plans to release its financial results for the third quarter in early November. The announcement marks an essential update for investors and stakeholders who are keen on the company’s financial performance. Details of the...
Continue Reading